P15. Crizotinib in metastatic ALK-positive lung cancer—results from clinical practice in Slovakia

BACKGROUND: Crizotinib was approved and authorized for use in the European Union in October 2012. Since then crizotinib has been available in Slovakia for treatment of advanced metastatic non-small cell lung cancer (NSCLC) after failure of standard chemotherapy only, based on the wording of the ther...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Lung Cancer Res
Main Authors: Berzinec, Peter, Kasan, Peter, Plank, Lukas, Andrasina, Igor, Godal, Robert, Mazal, Juraj, Cipkova, Andrea, Denkova, Lucia, Chowaniecova, Gabriela, Kuliskova, Iveta
Formato: Artigo
Idioma:Inglês
Publicado em: Pioneer Bioscience Publishing Company 2014
Assuntos:
CELCC 2014 Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4367737/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2014.AB027
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados